

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.37636745 |
| 2 | vocalization behavior (GO:0071625) | 5.89281788 |
| 3 | locomotory exploration behavior (GO:0035641) | 5.74673298 |
| 4 | synaptic vesicle maturation (GO:0016188) | 5.73843492 |
| 5 | * positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.60122682 |
| 6 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.53296659 |
| 7 | * synaptic vesicle exocytosis (GO:0016079) | 5.53142941 |
| 8 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.49943719 |
| 9 | * glutamate secretion (GO:0014047) | 5.29428911 |
| 10 | neuronal action potential propagation (GO:0019227) | 5.23324898 |
| 11 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.16941115 |
| 12 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.16605242 |
| 13 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.06055274 |
| 14 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.05346497 |
| 15 | protein localization to synapse (GO:0035418) | 5.03768161 |
| 16 | neuron cell-cell adhesion (GO:0007158) | 4.93379058 |
| 17 | glutamate receptor signaling pathway (GO:0007215) | 4.63811076 |
| 18 | regulation of synaptic vesicle transport (GO:1902803) | 4.63381799 |
| 19 | * neurotransmitter secretion (GO:0007269) | 4.61942807 |
| 20 | synaptic transmission, glutamatergic (GO:0035249) | 4.61509874 |
| 21 | exploration behavior (GO:0035640) | 4.56837524 |
| 22 | neuron-neuron synaptic transmission (GO:0007270) | 4.42590075 |
| 23 | gamma-aminobutyric acid transport (GO:0015812) | 4.39319528 |
| 24 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.36836699 |
| 25 | * regulation of neuronal synaptic plasticity (GO:0048168) | 4.25930633 |
| 26 | layer formation in cerebral cortex (GO:0021819) | 4.25109520 |
| 27 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.24931438 |
| 28 | * regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.24720112 |
| 29 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.13628453 |
| 30 | dendritic spine morphogenesis (GO:0060997) | 4.04738024 |
| 31 | long-term memory (GO:0007616) | 4.03964548 |
| 32 | regulation of synapse structural plasticity (GO:0051823) | 4.00035915 |
| 33 | * regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.92526080 |
| 34 | positive regulation of synapse maturation (GO:0090129) | 3.91453839 |
| 35 | cellular potassium ion homeostasis (GO:0030007) | 3.87768824 |
| 36 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.86018113 |
| 37 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.83474453 |
| 38 | neuronal ion channel clustering (GO:0045161) | 3.82083883 |
| 39 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.79968057 |
| 40 | * regulation of postsynaptic membrane potential (GO:0060078) | 3.77329167 |
| 41 | * neurotransmitter transport (GO:0006836) | 3.76867470 |
| 42 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.75811178 |
| 43 | proline transport (GO:0015824) | 3.73232612 |
| 44 | synaptic vesicle endocytosis (GO:0048488) | 3.71064802 |
| 45 | * positive regulation of membrane potential (GO:0045838) | 3.70122716 |
| 46 | neuron recognition (GO:0008038) | 3.69717496 |
| 47 | L-amino acid import (GO:0043092) | 3.65579283 |
| 48 | transmission of nerve impulse (GO:0019226) | 3.61283613 |
| 49 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.60588905 |
| 50 | long-term synaptic potentiation (GO:0060291) | 3.59457509 |
| 51 | * regulation of synaptic plasticity (GO:0048167) | 3.59425344 |
| 52 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.54798692 |
| 53 | axon ensheathment in central nervous system (GO:0032291) | 3.52176643 |
| 54 | central nervous system myelination (GO:0022010) | 3.52176643 |
| 55 | * regulation of neurotransmitter levels (GO:0001505) | 3.50805738 |
| 56 | cerebellar granule cell differentiation (GO:0021707) | 3.48821290 |
| 57 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.48513787 |
| 58 | presynaptic membrane assembly (GO:0097105) | 3.47701562 |
| 59 | * regulation of neurotransmitter secretion (GO:0046928) | 3.46620565 |
| 60 | postsynaptic membrane organization (GO:0001941) | 3.44962715 |
| 61 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.40539346 |
| 62 | * regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.37362630 |
| 63 | sodium ion export (GO:0071436) | 3.36778668 |
| 64 | activation of protein kinase A activity (GO:0034199) | 3.36756818 |
| 65 | regulation of vesicle fusion (GO:0031338) | 3.36549133 |
| 66 | response to histamine (GO:0034776) | 3.35707392 |
| 67 | axonal fasciculation (GO:0007413) | 3.35531338 |
| 68 | amino acid import (GO:0043090) | 3.32969921 |
| 69 | neuromuscular process controlling balance (GO:0050885) | 3.30446343 |
| 70 | neuromuscular process controlling posture (GO:0050884) | 3.30243840 |
| 71 | * membrane depolarization (GO:0051899) | 3.29312909 |
| 72 | presynaptic membrane organization (GO:0097090) | 3.29090551 |
| 73 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.25367721 |
| 74 | positive regulation of neurotransmitter transport (GO:0051590) | 3.25235390 |
| 75 | mechanosensory behavior (GO:0007638) | 3.25015175 |
| 76 | membrane depolarization during action potential (GO:0086010) | 3.24387235 |
| 77 | potassium ion homeostasis (GO:0055075) | 3.23414546 |
| 78 | * regulation of neurotransmitter transport (GO:0051588) | 3.21075041 |
| 79 | auditory behavior (GO:0031223) | 3.18842193 |
| 80 | potassium ion import (GO:0010107) | 3.17606325 |
| 81 | regulation of synapse maturation (GO:0090128) | 3.15883758 |
| 82 | learning (GO:0007612) | 3.15830589 |
| 83 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.15319330 |
| 84 | regulation of dendritic spine development (GO:0060998) | 3.15218566 |
| 85 | social behavior (GO:0035176) | 3.14382756 |
| 86 | intraspecies interaction between organisms (GO:0051703) | 3.14382756 |
| 87 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.14140856 |
| 88 | synapse assembly (GO:0007416) | 3.13917572 |
| 89 | * synaptic transmission (GO:0007268) | 3.13595474 |
| 90 | serotonin metabolic process (GO:0042428) | 3.12011437 |
| 91 | prepulse inhibition (GO:0060134) | 3.11898236 |
| 92 | behavioral response to cocaine (GO:0048148) | 3.11313298 |
| 93 | response to auditory stimulus (GO:0010996) | 3.10967238 |
| 94 | cellular sodium ion homeostasis (GO:0006883) | 3.10098667 |
| 95 | dendrite morphogenesis (GO:0048813) | 3.09970485 |
| 96 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.09914359 |
| 97 | * calcium ion-dependent exocytosis (GO:0017156) | 3.09195915 |
| 98 | startle response (GO:0001964) | 3.08994208 |
| 99 | innervation (GO:0060384) | 3.08843117 |
| 100 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.08651123 |
| 101 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.08142699 |
| 102 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.07874845 |
| 103 | positive regulation of synaptic transmission (GO:0050806) | 3.07097355 |
| 104 | primary amino compound metabolic process (GO:1901160) | 3.06180804 |
| 105 | behavioral defense response (GO:0002209) | 3.06018886 |
| 106 | behavioral fear response (GO:0001662) | 3.06018886 |
| 107 | positive regulation of dendritic spine development (GO:0060999) | 3.05535916 |
| 108 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.05340077 |
| 109 | * regulation of synaptic transmission (GO:0050804) | 3.05129567 |
| 110 | neuromuscular synaptic transmission (GO:0007274) | 3.04875663 |
| 111 | * membrane hyperpolarization (GO:0060081) | 3.03224083 |
| 112 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.02423603 |
| 113 | C4-dicarboxylate transport (GO:0015740) | 3.01912959 |
| 114 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.01631070 |
| 115 | long term synaptic depression (GO:0060292) | 3.00908808 |
| 116 | acidic amino acid transport (GO:0015800) | 2.99310930 |
| 117 | adult walking behavior (GO:0007628) | 2.99170968 |
| 118 | cell differentiation in hindbrain (GO:0021533) | 2.97286772 |
| 119 | neuromuscular process (GO:0050905) | 2.96722220 |
| 120 | dendritic spine organization (GO:0097061) | 2.91085490 |
| 121 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.90633040 |
| 122 | cell communication by electrical coupling (GO:0010644) | 2.88717329 |
| 123 | establishment of mitochondrion localization (GO:0051654) | 2.86221641 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.34211690 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.80753682 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.14765452 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.08213761 |
| 5 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.07186572 |
| 6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.75165726 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.73019354 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.73019354 |
| 9 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.60800227 |
| 10 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.57075104 |
| 11 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.49012434 |
| 12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.48589282 |
| 13 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.48407816 |
| 14 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.45812021 |
| 15 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.45198889 |
| 16 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.43828408 |
| 17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.42922414 |
| 18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.24812202 |
| 19 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.20131457 |
| 20 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.17962347 |
| 21 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.17505176 |
| 22 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.16510618 |
| 23 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.06792749 |
| 24 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.00763926 |
| 25 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.94376196 |
| 26 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.93261039 |
| 27 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.90980525 |
| 28 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.89519683 |
| 29 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.85377387 |
| 30 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.81953281 |
| 31 | * ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.81898348 |
| 32 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.77763207 |
| 33 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.76618631 |
| 34 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.74451463 |
| 35 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.64097618 |
| 36 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.58833841 |
| 37 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.52543402 |
| 38 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.50666821 |
| 39 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.49071464 |
| 40 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.46797670 |
| 41 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.45316769 |
| 42 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.41878906 |
| 43 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.40526409 |
| 44 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.37601644 |
| 45 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.37226108 |
| 46 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.34799798 |
| 47 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.34759472 |
| 48 | AR_25329375_ChIP-Seq_VCAP_Human | 1.33175552 |
| 49 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.31296593 |
| 50 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.30968340 |
| 51 | STAT3_23295773_ChIP-Seq_U87_Human | 1.30404561 |
| 52 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.28765612 |
| 53 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.26602319 |
| 54 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.24097001 |
| 55 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.24081738 |
| 56 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.24074385 |
| 57 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.24051157 |
| 58 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.23722537 |
| 59 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.22231178 |
| 60 | * AR_19668381_ChIP-Seq_PC3_Human | 1.21695682 |
| 61 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.18109606 |
| 62 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.17786567 |
| 63 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.17341821 |
| 64 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.17318935 |
| 65 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.17277748 |
| 66 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.14752414 |
| 67 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.14599599 |
| 68 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.13576055 |
| 69 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.10425262 |
| 70 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.09631860 |
| 71 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.09191648 |
| 72 | FUS_26573619_Chip-Seq_HEK293_Human | 1.08030142 |
| 73 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.07733060 |
| 74 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.07394004 |
| 75 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.06982710 |
| 76 | TP53_16413492_ChIP-PET_HCT116_Human | 1.06767062 |
| 77 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.05830061 |
| 78 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.04578766 |
| 79 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.03362050 |
| 80 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.03141997 |
| 81 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.03057939 |
| 82 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.02455202 |
| 83 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01908943 |
| 84 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.01908943 |
| 85 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.01731495 |
| 86 | * KDM2B_26808549_Chip-Seq_REH_Human | 1.00704838 |
| 87 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.00368522 |
| 88 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.99404501 |
| 89 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.99322625 |
| 90 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.98205663 |
| 91 | * CBP_20019798_ChIP-Seq_JUKART_Human | 0.98033260 |
| 92 | * IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.98033260 |
| 93 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.98021139 |
| 94 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.97397123 |
| 95 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97277520 |
| 96 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.97255097 |
| 97 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96506425 |
| 98 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.95254874 |
| 99 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.94807223 |
| 100 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.94542492 |
| 101 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.93827384 |
| 102 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.92817729 |
| 103 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.91671459 |
| 104 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.90975187 |
| 105 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.90694645 |
| 106 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.90283395 |
| 107 | * JUN_21703547_ChIP-Seq_K562_Human | 0.89396657 |
| 108 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.89254285 |
| 109 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.89055086 |
| 110 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89041485 |
| 111 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.88489894 |
| 112 | VDR_22108803_ChIP-Seq_LS180_Human | 0.88440389 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0004859_abnormal_synaptic_plasticity | 6.30181613 |
| 2 | MP0003880_abnormal_central_pattern | 5.02841835 |
| 3 | * MP0003635_abnormal_synaptic_transmissio | 4.31061767 |
| 4 | MP0004270_analgesia | 3.78352067 |
| 5 | MP0009046_muscle_twitch | 3.61931841 |
| 6 | MP0009745_abnormal_behavioral_response | 3.59492978 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.42017352 |
| 8 | MP0002064_seizures | 3.36942456 |
| 9 | MP0001968_abnormal_touch/_nociception | 3.15604664 |
| 10 | MP0002572_abnormal_emotion/affect_behav | 2.95492713 |
| 11 | MP0005423_abnormal_somatic_nervous | 2.81463697 |
| 12 | MP0002272_abnormal_nervous_system | 2.78503058 |
| 13 | MP0002734_abnormal_mechanical_nocicepti | 2.78012801 |
| 14 | MP0001486_abnormal_startle_reflex | 2.71505353 |
| 15 | MP0001501_abnormal_sleep_pattern | 2.44677570 |
| 16 | MP0002736_abnormal_nociception_after | 2.42815759 |
| 17 | MP0002735_abnormal_chemical_nociception | 2.38263329 |
| 18 | MP0002822_catalepsy | 2.32041440 |
| 19 | MP0001440_abnormal_grooming_behavior | 2.23623029 |
| 20 | MP0002067_abnormal_sensory_capabilities | 2.15305702 |
| 21 | MP0008569_lethality_at_weaning | 2.05274327 |
| 22 | MP0002733_abnormal_thermal_nociception | 2.05002286 |
| 23 | MP0001970_abnormal_pain_threshold | 2.00015917 |
| 24 | * MP0002184_abnormal_innervation | 1.84905453 |
| 25 | MP0005386_behavior/neurological_phenoty | 1.82803054 |
| 26 | MP0004924_abnormal_behavior | 1.82803054 |
| 27 | MP0000778_abnormal_nervous_system | 1.80198309 |
| 28 | MP0003329_amyloid_beta_deposits | 1.79929950 |
| 29 | * MP0002557_abnormal_social/conspecific_i | 1.77180740 |
| 30 | MP0001984_abnormal_olfaction | 1.77013939 |
| 31 | MP0009780_abnormal_chondrocyte_physiolo | 1.74171825 |
| 32 | MP0004811_abnormal_neuron_physiology | 1.70632451 |
| 33 | MP0006276_abnormal_autonomic_nervous | 1.67442998 |
| 34 | MP0003879_abnormal_hair_cell | 1.66383384 |
| 35 | MP0004858_abnormal_nervous_system | 1.58386528 |
| 36 | MP0005646_abnormal_pituitary_gland | 1.58118316 |
| 37 | MP0005410_abnormal_fertilization | 1.56478993 |
| 38 | MP0002909_abnormal_adrenal_gland | 1.54005798 |
| 39 | * MP0000955_abnormal_spinal_cord | 1.47686210 |
| 40 | MP0002066_abnormal_motor_capabilities/c | 1.47531314 |
| 41 | * MP0002882_abnormal_neuron_morphology | 1.43087434 |
| 42 | MP0003787_abnormal_imprinting | 1.39605280 |
| 43 | MP0004885_abnormal_endolymph | 1.38935960 |
| 44 | MP0001905_abnormal_dopamine_level | 1.36390984 |
| 45 | MP0001502_abnormal_circadian_rhythm | 1.34852019 |
| 46 | MP0004142_abnormal_muscle_tone | 1.34328638 |
| 47 | MP0003633_abnormal_nervous_system | 1.31978684 |
| 48 | MP0001529_abnormal_vocalization | 1.31717772 |
| 49 | MP0001188_hyperpigmentation | 1.18667691 |
| 50 | MP0003631_nervous_system_phenotype | 1.18565722 |
| 51 | MP0003123_paternal_imprinting | 1.18486709 |
| 52 | MP0004145_abnormal_muscle_electrophysio | 1.18133155 |
| 53 | MP0005645_abnormal_hypothalamus_physiol | 1.12843494 |
| 54 | MP0005551_abnormal_eye_electrophysiolog | 1.12629416 |
| 55 | * MP0002152_abnormal_brain_morphology | 1.11013417 |
| 56 | MP0008872_abnormal_physiological_respon | 1.10419763 |
| 57 | MP0000569_abnormal_digit_pigmentation | 1.10148770 |
| 58 | MP0004742_abnormal_vestibular_system | 1.09688914 |
| 59 | MP0008877_abnormal_DNA_methylation | 1.07267559 |
| 60 | MP0010386_abnormal_urinary_bladder | 1.04094375 |
| 61 | MP0002229_neurodegeneration | 1.02750914 |
| 62 | MP0003122_maternal_imprinting | 0.98357940 |
| 63 | MP0001348_abnormal_lacrimal_gland | 0.98278842 |
| 64 | MP0003632_abnormal_nervous_system | 0.94907859 |
| 65 | MP0000751_myopathy | 0.94390728 |
| 66 | MP0008874_decreased_physiological_sensi | 0.92882492 |
| 67 | MP0001177_atelectasis | 0.92396478 |
| 68 | MP0002069_abnormal_eating/drinking_beha | 0.91516569 |
| 69 | MP0001963_abnormal_hearing_physiology | 0.89667507 |
| 70 | MP0003121_genomic_imprinting | 0.87903958 |
| 71 | MP0003698_abnormal_male_reproductive | 0.86785872 |
| 72 | MP0001986_abnormal_taste_sensitivity | 0.86719381 |
| 73 | MP0004085_abnormal_heartbeat | 0.81844371 |
| 74 | MP0005253_abnormal_eye_physiology | 0.80548551 |
| 75 | MP0005499_abnormal_olfactory_system | 0.80444574 |
| 76 | MP0005394_taste/olfaction_phenotype | 0.80444574 |
| 77 | MP0002837_dystrophic_cardiac_calcinosis | 0.79510975 |
| 78 | MP0005535_abnormal_body_temperature | 0.79334974 |
| 79 | * MP0002752_abnormal_somatic_nervous | 0.77812286 |
| 80 | MP0000920_abnormal_myelination | 0.75440869 |
| 81 | MP0001299_abnormal_eye_distance/ | 0.74640707 |
| 82 | MP0003634_abnormal_glial_cell | 0.74508862 |
| 83 | MP0004215_abnormal_myocardial_fiber | 0.74288127 |
| 84 | MP0000013_abnormal_adipose_tissue | 0.74247136 |
| 85 | MP0000631_abnormal_neuroendocrine_gland | 0.73961972 |
| 86 | MP0000604_amyloidosis | 0.73343721 |
| 87 | MP0004147_increased_porphyrin_level | 0.72058155 |
| 88 | MP0003690_abnormal_glial_cell | 0.71280091 |
| 89 | MP0004484_altered_response_of | 0.71102689 |
| 90 | MP0001485_abnormal_pinna_reflex | 0.69659779 |
| 91 | MP0002638_abnormal_pupillary_reflex | 0.68949570 |
| 92 | MP0002090_abnormal_vision | 0.67974459 |
| 93 | MP0008961_abnormal_basal_metabolism | 0.64396673 |
| 94 | MP0003075_altered_response_to | 0.64345756 |
| 95 | MP0003137_abnormal_impulse_conducting | 0.63555448 |
| 96 | MP0000579_abnormal_nail_morphology | 0.63125698 |
| 97 | MP0001664_abnormal_digestion | 0.62432027 |
| 98 | MP0003938_abnormal_ear_development | 0.61309001 |
| 99 | MP0005623_abnormal_meninges_morphology | 0.60975972 |
| 100 | MP0004510_myositis | 0.60837590 |
| 101 | MP0002876_abnormal_thyroid_physiology | 0.60635718 |
| 102 | MP0004133_heterotaxia | 0.59936102 |
| 103 | MP0004130_abnormal_muscle_cell | 0.59500086 |
| 104 | MP0004233_abnormal_muscle_weight | 0.59255770 |
| 105 | MP0005409_darkened_coat_color | 0.58407272 |
| 106 | MP0005187_abnormal_penis_morphology | 0.56410841 |
| 107 | MP0003861_abnormal_nervous_system | 0.55619142 |
| 108 | MP0001943_abnormal_respiration | 0.55419684 |
| 109 | MP0001346_abnormal_lacrimal_gland | 0.53727595 |
| 110 | * MP0010769_abnormal_survival | 0.53461523 |
| 111 | MP0005670_abnormal_white_adipose | 0.53057285 |
| 112 | MP0002234_abnormal_pharynx_morphology | 0.52570298 |
| 113 | * MP0010770_preweaning_lethality | 0.52095106 |
| 114 | * MP0002082_postnatal_lethality | 0.52095106 |
| 115 | MP0003646_muscle_fatigue | 0.51755446 |
| 116 | MP0004043_abnormal_pH_regulation | 0.51713140 |
| 117 | * MP0010768_mortality/aging | 0.50462690 |
| 118 | MP0003956_abnormal_body_size | 0.49937797 |
| 119 | MP0000026_abnormal_inner_ear | 0.49802263 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.44285212 |
| 2 | Myokymia (HP:0002411) | 6.74399670 |
| 3 | Focal seizures (HP:0007359) | 6.15642510 |
| 4 | Visual hallucinations (HP:0002367) | 5.53399738 |
| 5 | Atonic seizures (HP:0010819) | 5.39399301 |
| 6 | Epileptic encephalopathy (HP:0200134) | 5.30047252 |
| 7 | Febrile seizures (HP:0002373) | 5.15241480 |
| 8 | Progressive cerebellar ataxia (HP:0002073) | 4.84201122 |
| 9 | Absence seizures (HP:0002121) | 4.55674446 |
| 10 | Action tremor (HP:0002345) | 4.16162251 |
| 11 | Dialeptic seizures (HP:0011146) | 4.13403387 |
| 12 | Generalized tonic-clonic seizures (HP:0002069) | 4.13351926 |
| 13 | Broad-based gait (HP:0002136) | 4.05643182 |
| 14 | Gaze-evoked nystagmus (HP:0000640) | 4.05636378 |
| 15 | Hyperventilation (HP:0002883) | 3.77381247 |
| 16 | Poor eye contact (HP:0000817) | 3.57120754 |
| 17 | Dysdiadochokinesis (HP:0002075) | 3.46865294 |
| 18 | Dysmetria (HP:0001310) | 3.23361510 |
| 19 | Supranuclear gaze palsy (HP:0000605) | 3.22080016 |
| 20 | Impaired social interactions (HP:0000735) | 3.20602499 |
| 21 | Abnormal social behavior (HP:0012433) | 3.20602499 |
| 22 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.20366461 |
| 23 | Truncal ataxia (HP:0002078) | 3.19065157 |
| 24 | Ankle clonus (HP:0011448) | 3.14721715 |
| 25 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.11368610 |
| 26 | Amblyopia (HP:0000646) | 3.04708868 |
| 27 | Depression (HP:0000716) | 3.03945893 |
| 28 | Genetic anticipation (HP:0003743) | 3.01834976 |
| 29 | Impaired smooth pursuit (HP:0007772) | 2.99490424 |
| 30 | Mutism (HP:0002300) | 2.94845477 |
| 31 | Abnormal eating behavior (HP:0100738) | 2.90492251 |
| 32 | Anxiety (HP:0000739) | 2.90205061 |
| 33 | Scanning speech (HP:0002168) | 2.89953053 |
| 34 | Progressive inability to walk (HP:0002505) | 2.80474654 |
| 35 | Excessive salivation (HP:0003781) | 2.79969556 |
| 36 | Drooling (HP:0002307) | 2.79969556 |
| 37 | Postural instability (HP:0002172) | 2.78700459 |
| 38 | Papilledema (HP:0001085) | 2.75670052 |
| 39 | Hemiparesis (HP:0001269) | 2.73866108 |
| 40 | Dysmetric saccades (HP:0000641) | 2.71344244 |
| 41 | Abnormality of binocular vision (HP:0011514) | 2.69965985 |
| 42 | Diplopia (HP:0000651) | 2.69965985 |
| 43 | Fetal akinesia sequence (HP:0001989) | 2.64724037 |
| 44 | Limb dystonia (HP:0002451) | 2.63753635 |
| 45 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.62386751 |
| 46 | Absent speech (HP:0001344) | 2.61729348 |
| 47 | Abnormality of the lower motor neuron (HP:0002366) | 2.61516101 |
| 48 | Hemiplegia (HP:0002301) | 2.59162274 |
| 49 | Epileptiform EEG discharges (HP:0011182) | 2.57249817 |
| 50 | Urinary urgency (HP:0000012) | 2.55992931 |
| 51 | Intention tremor (HP:0002080) | 2.53795196 |
| 52 | Status epilepticus (HP:0002133) | 2.53164952 |
| 53 | Spastic gait (HP:0002064) | 2.52557928 |
| 54 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.48345168 |
| 55 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.48345168 |
| 56 | Stereotypic behavior (HP:0000733) | 2.46799795 |
| 57 | Cerebral inclusion bodies (HP:0100314) | 2.45000179 |
| 58 | EEG with generalized epileptiform discharges (HP:0011198) | 2.43646085 |
| 59 | Neurofibrillary tangles (HP:0002185) | 2.39757967 |
| 60 | Bradykinesia (HP:0002067) | 2.38748880 |
| 61 | Inability to walk (HP:0002540) | 2.38038341 |
| 62 | Torticollis (HP:0000473) | 2.35807020 |
| 63 | Insidious onset (HP:0003587) | 2.34128617 |
| 64 | Termporal pattern (HP:0011008) | 2.34128617 |
| 65 | Abnormality of the corticospinal tract (HP:0002492) | 2.30920637 |
| 66 | Generalized myoclonic seizures (HP:0002123) | 2.29723407 |
| 67 | Impaired vibratory sensation (HP:0002495) | 2.28932825 |
| 68 | Hypsarrhythmia (HP:0002521) | 2.27635429 |
| 69 | Focal dystonia (HP:0004373) | 2.25497532 |
| 70 | Akinesia (HP:0002304) | 2.24453759 |
| 71 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.22658803 |
| 72 | Pheochromocytoma (HP:0002666) | 2.18149000 |
| 73 | Spastic tetraplegia (HP:0002510) | 2.14200520 |
| 74 | Spastic tetraparesis (HP:0001285) | 2.12816456 |
| 75 | Ventricular fibrillation (HP:0001663) | 2.10818288 |
| 76 | Gait ataxia (HP:0002066) | 2.10490266 |
| 77 | Polyphagia (HP:0002591) | 2.09555126 |
| 78 | Annular pancreas (HP:0001734) | 2.07582252 |
| 79 | Chronic hepatic failure (HP:0100626) | 2.01894573 |
| 80 | Protruding tongue (HP:0010808) | 2.01233238 |
| 81 | Lower limb muscle weakness (HP:0007340) | 2.01144420 |
| 82 | Incomplete penetrance (HP:0003829) | 1.99720748 |
| 83 | Agitation (HP:0000713) | 1.96921293 |
| 84 | Amyotrophic lateral sclerosis (HP:0007354) | 1.96690641 |
| 85 | Megalencephaly (HP:0001355) | 1.93973393 |
| 86 | Cerebral hypomyelination (HP:0006808) | 1.93860690 |
| 87 | Blue irides (HP:0000635) | 1.93335019 |
| 88 | Craniofacial dystonia (HP:0012179) | 1.92381634 |
| 89 | Tetraplegia (HP:0002445) | 1.92236914 |
| 90 | Gait imbalance (HP:0002141) | 1.90343788 |
| 91 | Abnormality of salivation (HP:0100755) | 1.88781834 |
| 92 | Obstructive sleep apnea (HP:0002870) | 1.87734161 |
| 93 | Neuroendocrine neoplasm (HP:0100634) | 1.87541603 |
| 94 | Inappropriate behavior (HP:0000719) | 1.86169800 |
| 95 | Abnormality of saccadic eye movements (HP:0000570) | 1.85916171 |
| 96 | Paraplegia (HP:0010550) | 1.85574715 |
| 97 | Neuronal loss in central nervous system (HP:0002529) | 1.85279672 |
| 98 | Specific learning disability (HP:0001328) | 1.84241997 |
| 99 | Delusions (HP:0000746) | 1.83180269 |
| 100 | Lower limb asymmetry (HP:0100559) | 1.81433505 |
| 101 | Sleep apnea (HP:0010535) | 1.81414037 |
| 102 | Pointed chin (HP:0000307) | 1.79442310 |
| 103 | Psychosis (HP:0000709) | 1.77678402 |
| 104 | Spastic paraplegia (HP:0001258) | 1.77341654 |
| 105 | Oligodactyly (hands) (HP:0001180) | 1.73305571 |
| 106 | Hepatoblastoma (HP:0002884) | 1.72112086 |
| 107 | Hypoplasia of the corpus callosum (HP:0002079) | 1.72050566 |
| 108 | Clonus (HP:0002169) | 1.71133238 |
| 109 | Rigidity (HP:0002063) | 1.69848703 |
| 110 | Horizontal nystagmus (HP:0000666) | 1.69693675 |
| 111 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.65256807 |
| 112 | Postural tremor (HP:0002174) | 1.64402076 |
| 113 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.63717420 |
| 114 | Absent/shortened dynein arms (HP:0200106) | 1.63717420 |
| 115 | Limb ataxia (HP:0002070) | 1.63664591 |
| 116 | Prolonged QT interval (HP:0001657) | 1.62421302 |
| 117 | Generalized hypopigmentation of hair (HP:0011358) | 1.60460555 |
| 118 | Rapidly progressive (HP:0003678) | 1.60124468 |
| 119 | Peripheral hypomyelination (HP:0007182) | 1.59562454 |
| 120 | Intellectual disability, severe (HP:0010864) | 1.59144991 |
| 121 | Abnormality of the labia minora (HP:0012880) | 1.58766405 |
| 122 | Optic nerve hypoplasia (HP:0000609) | 1.56508373 |
| 123 | Increased circulating renin level (HP:0000848) | 1.56188455 |
| 124 | Nephronophthisis (HP:0000090) | 1.53642631 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.22514443 |
| 2 | EPHA4 | 4.17575477 |
| 3 | MAP3K9 | 3.85496633 |
| 4 | MAP3K4 | 3.35876353 |
| 5 | MAP2K7 | 2.91329208 |
| 6 | MARK1 | 2.82465182 |
| 7 | DAPK2 | 2.73492789 |
| 8 | MINK1 | 2.55760430 |
| 9 | CASK | 2.32494535 |
| 10 | MAP3K12 | 2.25386279 |
| 11 | PAK6 | 2.25027756 |
| 12 | NTRK2 | 2.20268171 |
| 13 | MAP2K4 | 2.14321816 |
| 14 | KSR2 | 1.95456627 |
| 15 | RIPK4 | 1.93963916 |
| 16 | PNCK | 1.83319068 |
| 17 | PRKD3 | 1.80680154 |
| 18 | CAMKK1 | 1.75969557 |
| 19 | DAPK1 | 1.72434357 |
| 20 | NTRK1 | 1.68840718 |
| 21 | PLK2 | 1.57399118 |
| 22 | CDK19 | 1.56970510 |
| 23 | TNIK | 1.56968085 |
| 24 | KSR1 | 1.55842889 |
| 25 | CDK5 | 1.51547563 |
| 26 | MAPK13 | 1.47820861 |
| 27 | GRK5 | 1.45790836 |
| 28 | SIK2 | 1.43582585 |
| 29 | CAMKK2 | 1.37811448 |
| 30 | ARAF | 1.36757128 |
| 31 | STK38 | 1.34828748 |
| 32 | PRPF4B | 1.34130555 |
| 33 | PRKCG | 1.20091899 |
| 34 | STK39 | 1.19196390 |
| 35 | MAP3K13 | 1.17824541 |
| 36 | FES | 1.12164754 |
| 37 | CAMK2A | 1.07824503 |
| 38 | LATS2 | 1.03094667 |
| 39 | TYRO3 | 1.02981631 |
| 40 | WNK4 | 1.02589780 |
| 41 | FRK | 1.01455740 |
| 42 | CAMK1 | 0.98570978 |
| 43 | UHMK1 | 0.96746871 |
| 44 | BRSK1 | 0.96579927 |
| 45 | OXSR1 | 0.94420838 |
| 46 | CDK18 | 0.92146063 |
| 47 | SGK223 | 0.91275668 |
| 48 | SGK494 | 0.91275668 |
| 49 | STK11 | 0.91233131 |
| 50 | CDK15 | 0.90717872 |
| 51 | PKN1 | 0.89124809 |
| 52 | CAMK2B | 0.87802349 |
| 53 | BMPR2 | 0.87644681 |
| 54 | RAF1 | 0.85419384 |
| 55 | CDK14 | 0.84790828 |
| 56 | TAOK1 | 0.83979755 |
| 57 | SGK2 | 0.83079152 |
| 58 | MAP3K2 | 0.82217424 |
| 59 | PHKG2 | 0.80450189 |
| 60 | PHKG1 | 0.80450189 |
| 61 | CDK11A | 0.78863066 |
| 62 | RET | 0.76427606 |
| 63 | PTK2B | 0.74336573 |
| 64 | PLK4 | 0.74163869 |
| 65 | DYRK1A | 0.71808359 |
| 66 | CSNK1G2 | 0.71463567 |
| 67 | PRKCH | 0.70793952 |
| 68 | SGK1 | 0.70444401 |
| 69 | PINK1 | 0.70304182 |
| 70 | PAK3 | 0.66824038 |
| 71 | MAP3K6 | 0.66123745 |
| 72 | CCNB1 | 0.65960384 |
| 73 | CAMK1D | 0.64495766 |
| 74 | SGK3 | 0.63524765 |
| 75 | MARK2 | 0.63073563 |
| 76 | CAMK1G | 0.62891332 |
| 77 | STK38L | 0.62041440 |
| 78 | INSRR | 0.58404655 |
| 79 | TNK2 | 0.57303444 |
| 80 | PDK1 | 0.56787802 |
| 81 | DYRK2 | 0.55408085 |
| 82 | CAMK2D | 0.54587479 |
| 83 | FGR | 0.53945287 |
| 84 | PDPK1 | 0.52072889 |
| 85 | MAP4K2 | 0.51401278 |
| 86 | CAMK2G | 0.51107291 |
| 87 | WNK1 | 0.50985964 |
| 88 | PRKCE | 0.50922856 |
| 89 | CSNK1A1L | 0.48709980 |
| 90 | ALK | 0.48616575 |
| 91 | AKT3 | 0.48214171 |
| 92 | CAMK4 | 0.47981164 |
| 93 | CDC42BPA | 0.47894356 |
| 94 | RPS6KA3 | 0.47619820 |
| 95 | MAPKAPK5 | 0.47367337 |
| 96 | PRKCZ | 0.46267694 |
| 97 | NME1 | 0.45364921 |
| 98 | RIPK1 | 0.45114139 |
| 99 | MAP3K1 | 0.44968026 |
| 100 | MUSK | 0.44244701 |
| 101 | BRAF | 0.44024536 |
| 102 | NEK6 | 0.42887048 |
| 103 | BCR | 0.42019440 |
| 104 | LMTK2 | 0.41888814 |
| 105 | PRKG1 | 0.41759955 |
| 106 | ADRBK2 | 0.41624506 |
| 107 | FYN | 0.41126330 |
| 108 | MAPK10 | 0.40866627 |
| 109 | FGFR2 | 0.39836507 |
| 110 | * PRKACA | 0.39157111 |
| 111 | ROCK2 | 0.38967916 |
| 112 | DAPK3 | 0.38649934 |
| 113 | * GSK3B | 0.38497693 |
| 114 | CSNK1D | 0.38232429 |
| 115 | CSNK1G3 | 0.37352993 |
| 116 | MAP2K1 | 0.35818773 |
| 117 | MAPK8 | 0.35333319 |
| 118 | MAPK12 | 0.35293145 |
| 119 | PRKCA | 0.34938027 |
| 120 | WNK3 | 0.34491179 |
| 121 | * CSNK1E | 0.33530692 |
| 122 | MAP3K7 | 0.32023858 |
| 123 | DYRK1B | 0.31183581 |
| 124 | PRKCB | 0.30838846 |
| 125 | BMPR1B | 0.28685422 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.11428011 |
| 2 | * Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.33913996 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.82387193 |
| 4 | * Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.82169285 |
| 5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.76472344 |
| 6 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.74835193 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.72630495 |
| 8 | Olfactory transduction_Homo sapiens_hsa04740 | 2.72090070 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.59813134 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.48792999 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 2.23052889 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.19838332 |
| 13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.08092062 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 2.00436745 |
| 15 | Taste transduction_Homo sapiens_hsa04742 | 1.98128793 |
| 16 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.89937148 |
| 17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.89900612 |
| 18 | Long-term depression_Homo sapiens_hsa04730 | 1.85286152 |
| 19 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.83903036 |
| 20 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.78104205 |
| 21 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.68726816 |
| 22 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.64834485 |
| 23 | Renin secretion_Homo sapiens_hsa04924 | 1.64511492 |
| 24 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.63261789 |
| 25 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.60521483 |
| 26 | Cocaine addiction_Homo sapiens_hsa05030 | 1.58568521 |
| 27 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.47840691 |
| 28 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.35565042 |
| 29 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.34965255 |
| 30 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.30835971 |
| 31 | Gap junction_Homo sapiens_hsa04540 | 1.29259586 |
| 32 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.27672535 |
| 33 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.27505630 |
| 34 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.19314246 |
| 35 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.16370188 |
| 36 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.15679618 |
| 37 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.15645275 |
| 38 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.12133967 |
| 39 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.10558927 |
| 40 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.08133622 |
| 41 | Axon guidance_Homo sapiens_hsa04360 | 1.04897405 |
| 42 | Glioma_Homo sapiens_hsa05214 | 1.02856666 |
| 43 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.02600418 |
| 44 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.01445091 |
| 45 | Phototransduction_Homo sapiens_hsa04744 | 1.00290121 |
| 46 | Melanogenesis_Homo sapiens_hsa04916 | 0.99050945 |
| 47 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.94057401 |
| 48 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.93119913 |
| 49 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.92368827 |
| 50 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.90704572 |
| 51 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.90497688 |
| 52 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.87737477 |
| 53 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.84563136 |
| 54 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.82859586 |
| 55 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.78721726 |
| 56 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.78197611 |
| 57 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.76751005 |
| 58 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.75948450 |
| 59 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.72854060 |
| 60 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.72416154 |
| 61 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.71766368 |
| 62 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.71258620 |
| 63 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.70587488 |
| 64 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.69048057 |
| 65 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.65383822 |
| 66 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.60505213 |
| 67 | Circadian rhythm_Homo sapiens_hsa04710 | 0.59651985 |
| 68 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.56089021 |
| 69 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.55971243 |
| 70 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.55553878 |
| 71 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.55353337 |
| 72 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.55299495 |
| 73 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.54657777 |
| 74 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.53626658 |
| 75 | Alzheimers disease_Homo sapiens_hsa05010 | 0.52517749 |
| 76 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.51354170 |
| 77 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.51163769 |
| 78 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50956910 |
| 79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.50831882 |
| 80 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.50609227 |
| 81 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.47939284 |
| 82 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.47000815 |
| 83 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.46340975 |
| 84 | Alcoholism_Homo sapiens_hsa05034 | 0.46011446 |
| 85 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.43040102 |
| 86 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.42875975 |
| 87 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.42438801 |
| 88 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.42189493 |
| 89 | Mineral absorption_Homo sapiens_hsa04978 | 0.41085829 |
| 90 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.40657940 |
| 91 | Bile secretion_Homo sapiens_hsa04976 | 0.40499410 |
| 92 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.40216951 |
| 93 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.39739273 |
| 94 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.39659559 |
| 95 | Endocytosis_Homo sapiens_hsa04144 | 0.38649116 |
| 96 | Tight junction_Homo sapiens_hsa04530 | 0.38314214 |
| 97 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.37021187 |
| 98 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.36218111 |
| 99 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.35679314 |
| 100 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.35633119 |
| 101 | Endometrial cancer_Homo sapiens_hsa05213 | 0.35146707 |
| 102 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.32773677 |
| 103 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.32594752 |
| 104 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.31732918 |
| 105 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.29693028 |
| 106 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.29347224 |
| 107 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.29288990 |
| 108 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.28864353 |
| 109 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.28434474 |
| 110 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.28138150 |
| 111 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.28027507 |
| 112 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.27568640 |
| 113 | Prion diseases_Homo sapiens_hsa05020 | 0.27549474 |
| 114 | Histidine metabolism_Homo sapiens_hsa00340 | 0.27159756 |
| 115 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.24560491 |
| 116 | ABC transporters_Homo sapiens_hsa02010 | 0.21307568 |

